Fibrosis Clinical Trials

• Pirfenidone for the Treatment of Patients with Pulmonary Fibrosis/Idiopathic Pulmonary Fibrosis (PF/IPF)
  ClinicalTrials.gov Identifier: NCT00080223 - Active, not recruiting
  Idiopathic Pulmonary Fibrosis; Pulmonary Fibrosis
  
• Can Quantitative Ultrasound Be Used for the Evaluation of Bone Health in Adolescents and Adults with Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00221572 - Recruiting
  Cystic Fibrosis
  
• Study of Total Energy Expenditure in Infants and Children With Moderate to Severe Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00006273 - Active, not recruiting
  Cystic Fibrosis
  
• A Study to Evaluate Nutropin AQ for the Treatment of Growth Restriction in Children with Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00079742 - Active, not recruiting
  Cystic Fibrosis
  
• Idiopathic Pulmonary Fibrosis
  ClinicalTrials.gov Identifier: NCT00063869 - Active, not recruiting
  Pulmonary Fibrosis
  
• Tissue Collection from People with Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00015756 - Active, not recruiting
  Cystic Fibrosis
  
• Study of Hepatic Glucose Production and De novo Lipogenesis in Patients With Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00014781 - Recruiting
  Cystic Fibrosis
  
• Prevention of Disease Progress in Chronic Hepatitis C Patients with Liver Fibrosis
  ClinicalTrials.gov Identifier: NCT00049842 - Active, not recruiting
  Chronic Hepatitis C; Liver Fibrosis
  
• Behavioral & Nutritional Treatment to Help CF Preschoolers Grow
  ClinicalTrials.gov Identifier: NCT00241969 - Recruiting
  Cystic Fibrosis; Pancreatic Cystic Fibrosis
  
• Comparison of Inhaled Mannitol and rhDNase in Children with Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00117208 - Active, not recruiting
  Cystic Fibrosis
  
• Effect of Lubiprostone on Nutritional Status and Pulmonary Function in Adults With Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00577499 - Enrolling by invitation
  Cystic Fibrosis; Constipation; Nutrition
  
• Phase I Pilot Study of Gene Therapy for Cystic Fibrosis Using Cationic Liposome Mediated Gene Transfer
  ClinicalTrials.gov Identifier: NCT00004471 - Active, not recruiting
  Cystic Fibrosis
  
• Study of Denufosol Inhalation Solution in Patients With Mild Cystic Fibrosis Lung Disease
  ClinicalTrials.gov Identifier: NCT00357279 - Active, not recruiting
  Cystic Fibrosis
  
• Quantification of pulmonary neutrophil activity in cystic fibrosis using radiolabeled fluorodeoxyglucose and PET imaging
  ClinicalTrials.gov Identifier: NCT00023465 - Recruiting
  Cystic Fibrosis
  
• Efficacy and Safety of 28 or 56 Days Treatment With Inhaled Tobramycin Nebuliser Solution for Pseudomonas Aeruginosa Infection in Children With Cystic Fibrosis.
  ClinicalTrials.gov Identifier: NCT00391976 - Active, not recruiting
  Cystic Fibrosis
  
• Growth Hormone Treatment Study in Children With Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00256555 - Active, not recruiting
  Cystic Fibrosis
  
• Efficacy and Safety of Oral Bosentan in Patients with Idiopathic Pulmonary Fibrosis
  ClinicalTrials.gov Identifier: NCT00071461 - Active, not recruiting
  Idiopathic Pulmonary Fibrosis
  
• Safety Study of Aztreonam Lysinate for Inhalation (AI) in Cystic Fibrosis Patients with P. Aeruginosa
  ClinicalTrials.gov Identifier: NCT00128492 - Active, not recruiting
  Cystic Fibrosis
  
• Macrolide Antibiotic Therapy for Patients With Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00205634 - Active, not recruiting
  Cystic Fibrosis
  
• Growth Hormone Use in Adolescents and Adults With Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00287430 - Active, not recruiting
  Cystic Fibrosis
  
• Metabolic Abnormalities in Hispanic Children With Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00287443 - Active, not recruiting
  Cystic Fibrosis
  
• Prednisone Versus Tamoxifen in Idiopathic Retroperitoneal Fibrosis
  ClinicalTrials.gov Identifier: NCT00440349 - Active, not recruiting
  Retroperitoneal Fibrosis
  
• Zinc Homeostasis and Kinetics in Children with Cystic Fibrosis (CF)
  ClinicalTrials.gov Identifier: NCT00104494 - Recruiting
  Cystic Fibrosis
  
• Specimen Procurement from People with Hereditary Pulmonary Fibrosis
  ClinicalTrials.gov Identifier: NCT00084305 - Recruiting
  Pulmonary Fibrosis
  
• Fibrosis in Renal Allografts
  ClinicalTrials.gov Identifier: NCT00493194 - Recruiting
  Kidney Failure, Chronic; Transplantation; Immunosuppression; Interstitial Fibrosis
  
• Minocycline Therapy for Lung Scarring in Patients With Idiopathic Pulmonary Fibrosis - a Pilot Study
  ClinicalTrials.gov Identifier: NCT00203697 - Active, not recruiting
  Idiopathic Pulmonary Fibrosis
  
• Influence of DHA-Rich Supplement on DHA-Status and Health Evolution of Patients With Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00221546 - Active, not recruiting
  Cystic Fibrosis
  
• A Pilot Trial of Phenylbutyrate/Genistein Duotherapy (for Cystic Fibrosis)
  ClinicalTrials.gov Identifier: NCT00016744 - Recruiting
  Cystic Fibrosis
  
• Trental & Vitamin E for Radiation-Induced Fibrosis
  ClinicalTrials.gov Identifier: NCT00583700 - Recruiting
  Fibrosis
  
• Effectiveness of Pulmozyme in Infants With Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00179998 - Active, not recruiting
  Cystic Fibrosis
  
• Safety and Efficacy of PTC124 for Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00237380 - Active, not recruiting
  Cystic Fibrosis
  
• Pharmacokinetic Study of Lansoprazole in Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00458614 - Active, not recruiting
  Cystic Fibrosis
  
• Three-Arm Study of the Safety and Efficacy of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis
  ClinicalTrials.gov Identifier: NCT00287716 - Active, not recruiting
  Idiopathic Pulmonary Fibrosis
  
• Study of Alendronate to Prevent and Treat Osteoporosis in Cystic Fibrosis Patients
  ClinicalTrials.gov Identifier: NCT00157690 - Active, not recruiting
  Cystic Fibrosis; Osteoporosis; Bone Diseases, Metabolic
  
• Gene Modifiers in Cystic Fibrosis Lung Disease
  ClinicalTrials.gov Identifier: NCT00037765 - Active, not recruiting
  Cystic Fibrosis; Lung Diseases
  
• Randomized Study of Alendronate in Adult Patients With Cystic Fibrosis Related Osteoporosis
  ClinicalTrials.gov Identifier: NCT00004489 - Recruiting
  Osteoporosis; Cystic Fibrosis
  
• Phase II Pilot Study to Compare the Bioavailability of Buffered, Enteric-Coated Ursodiol with Unmodified Ursodiol for Chronic Cholestatic Liver Disease and Cystic Fibrosis-Associated Liver Disease
  ClinicalTrials.gov Identifier: NCT00004315 - Active, not recruiting
  Cystic Fibrosis; Gastrointestinal Diseases; Cholestasis
  
• Use of the Insulin Pump in Cystic Fibrosis Patients With Impaired Glucose Tolerance or CFRD and in Type 1 Diabetes Patients.
  ClinicalTrials.gov Identifier: NCT00287456 - Active, not recruiting
  Cystic Fibrosis Related Diabetes
  
• Safety and Efficacy of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis
  ClinicalTrials.gov Identifier: NCT00287729 - Active, not recruiting
  Idiopathic Pulmonary Fibrosis
  
• Phase I Randomized Study of Adeno-Associated Virus-CFTR Vector in Patients with Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00004533 - Active, not recruiting
  Cystic Fibrosis
  
• Nasal Inhalation of Dornase Alfa (Pulmozyme) in Patients With Cystic Fibrosis and Chronic Rhinosinusitis
  ClinicalTrials.gov Identifier: NCT00265434 - Active, not recruiting
  Cystic Fibrosis; Chronic Rhinosinusitis
  
• Phase II Study of Growth Hormone in Children With Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00016445 - Active, not recruiting
  Cystic Fibrosis
  
• Study of Denufosol Inhalation Solution in Patients With Mild to Moderate Cystic Fibrosis Lung Disease
  ClinicalTrials.gov Identifier: NCT00425165 - Recruiting
  Cystic Fibrosis
  
• Long Term Administration of Inhaled Dry Powder Mannitol In Cystic Fibrosis - A Safety and Efficacy Study
  ClinicalTrials.gov Identifier: NCT00446680 - Recruiting
  Cystic Fibrosis
  
• Prediction of Significant Hepatic Fibrosis in HCV Carriers With PNALT by SAPI- A Validation Study
  ClinicalTrials.gov Identifier: NCT00466271 - Recruiting
  Chronic Hepatitis C; Hepatic Fibrosis
  
• Phase II Study of the Safety and Efficacy of Inhaled Alpha-1 Antitrypsin (AAT ) in Cystic Fibrosis Patients
  ClinicalTrials.gov Identifier: NCT00499837 - Recruiting
  Cystic Fibrosis
  
• Efficacy of Prazosin Versus Placebo Associated with Peg-Interferon Alpha 2b and Ribavirin in Chronic Hepatitis C with Genotype 1 or 4 and Severe Fibrosis
  ClinicalTrials.gov Identifier: NCT00148837 - Active, not recruiting
  Hepatitis C, Chronic; Fibrosis
  
• Evaluation of a Decision Aid for Adult Cystic Fibrosis Patients Considering Bilateral Lung Transplantation
  ClinicalTrials.gov Identifier: NCT00345449 - Recruiting
  Cystic Fibrosis
  
• 18FDG- PET/CT Contribution to the Assessment of Lesion Severity in Cystic Fibrosis (CF)
  ClinicalTrials.gov Identifier: NCT00363402 - Recruiting
  Cystic Fibrosis
  
• Evaluation of the Safety and Efficacy of Pancrecarb® MS-16 in Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00432861 - Recruiting
  Cystic Fibrosis; Pancreatic Insufficiency
  
• The Prevalence and Significance of Gastro-Oesophageal Reflux in Cystic Fibrosis Before and After Lung Transplantation
  ClinicalTrials.gov Identifier: NCT00164021 - Recruiting
  Cystic Fibrosis
  
• Assessment of Quadriceps Muscle Electrostimulation Used in Patients Suffering From Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00391703 - Recruiting
  Cystic Fibrosis; Mucoviscidosis
  
• The Short Term Safety and Efficacy of Inhaled L-Arginine in Patients With Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00405665 - Recruiting
  Cystic Fibrosis
  
• Prolonging the Duration of Peripheral Venous Catheters in Cystic Fibrosis People
  ClinicalTrials.gov Identifier: NCT00418470 - Recruiting
  Cystic Fibrosis; Phlebitis
  
• Safety, Pharmacokinetic and Pharmacodynamic Study of MP-376 in Patients With Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00503490 - Recruiting
  Cystic Fibrosis
  
• Evaluation of the Emission Distance of P. Aeruginosa From the Respiratory Tract of People With Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00531531 - Recruiting
  Cystic Fibrosis
  
• Multidose Safety and Tolerability Study of (Arikace™) for Inhalation In Cystic Fibrosis Patients
  ClinicalTrials.gov Identifier: NCT00558844 - Recruiting
  Cystic Fibrosis
  
• A Pilot Study of Aerosol Interferon-Gamma for Treatment of Idiopathic Pulmonary Fibrosis
  ClinicalTrials.gov Identifier: NCT00563212 - Recruiting
  Pulmonary Fibrosis
  
• Efficacy and Safety Study of p144 to Treat Skin Fibrosis in Systemic Sclerosis
  ClinicalTrials.gov Identifier: NCT00574613 - Recruiting
  Skin Fibrosis
  
• Genetic Modifiers of Cystic Fibrosis: Sibling Study
  ClinicalTrials.gov Identifier: NCT00037778 - Recruiting
  Lung Diseases; Cystic Fibrosis
  
• Study of Tauroursodeoxycholic Acid for Hepatobiliary Disease in Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00004441 - Recruiting
  Cystic Fibrosis
  
• A Phase I Study of Inhaled Sodium Pyruvate for the Treatment of Cystic Fibrosis.
  ClinicalTrials.gov Identifier: NCT00332215 - Recruiting
  Cystic Fibrosis
  
• Efficacy and Safety Study of Inhaled Glutathione in Cystic Fibrosis Patients
  ClinicalTrials.gov Identifier: NCT00506688 - Recruiting
  Cystic Fibrosis
  
• Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QAU145 in Patients With Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00506792 - Recruiting
  Cystic Fibrosis
  
• Treatment of Aspergillus Fumigatus (a Fungal Infection) in Patients With Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00528190 - Recruiting
  Cystic Fibrosis
  
• Safety and Tolerability of Inhaled Nitric Oxide in Patients With Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00570349 - Recruiting
  Cystic Fibrosis
  
• Increased Gluconeogenesis is One Cause of Cystic Fibrosis Related Diabetes (CFRD)
  ClinicalTrials.gov Identifier: NCT00082238 - Recruiting
  Cystic Fibrosis; Diabetes Mellitus
  
• Treatment of Metabolic Alkalosis in Acute Exacerbations of Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00163852 - Recruiting
  Cystic Fibrosis
  
• Safety Study of VX 770 in Subjects With Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00457821 - Recruiting
  Cystic Fibrosis
  
• Safety And Efficacy of BIBF 1120 in Idiopathic Pulmonary Fibrosis
  ClinicalTrials.gov Identifier: NCT00514683 - Recruiting
  Pulmonary Fibrosis
  
• Tolerability of Inhaled Hypertonic Saline in Infants With Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00546663 - Recruiting
  Cystic Fibrosis
  
• Non-Invasive Ventilation and Oxygen Therapy in Cystic Fibrosis Patients with Nocturnal Oxygen Desaturation
  ClinicalTrials.gov Identifier: NCT00157183 - Recruiting
  Cystic Fibrosis
  
• The Influence of Personality on Pulmonary Fibrosis and Sarcoidosis
  ClinicalTrials.gov Identifier: NCT00504621 - Enrolling by invitation
  Sarcoidosis; Pulmonary Fibrosis
  
• Zileuton for the Treatment of Idiopathic Pulmonary Fibrosis
  ClinicalTrials.gov Identifier: NCT00262405 - Active, not recruiting
  Idiopathic Pulmonary Fibrosis
  
• Sildenafil Study to Treat Idiopathic Pulmonary Fibrosis
  ClinicalTrials.gov Identifier: NCT00359736 - Recruiting
  Fibrosis, Pulmonary; Alveolitis, Fibrosing; Hypertension, Pulmonary; Exercise, Aerobic
  
• Mannitol Dose Response Study in Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00251056 - Recruiting
  Cystic Fibrosis
  
• Genetic Polymorphisms in Idiopathic Pulmonary Fibrosis (IPF)
  ClinicalTrials.gov Identifier: NCT00258570 - Recruiting
  Pulmonary Fibrosis
  
• Inhaled Sodium Pyruvate for the Treatment of Cystic Fibrosis.
  ClinicalTrials.gov Identifier: NCT00308243 - Recruiting
  Cystic Fibrosis
  
• Disclosing a Cystic Fibrosis Diagnosis to a Dating Partner
  ClinicalTrials.gov Identifier: NCT00485082 - Recruiting
  Cystic Fibrosis
  
• Use of Formula Fortified With DHA in Infants With Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00530244 - Recruiting
  Cystic Fibrosis
  
• Miglustat / OGT 918 in the Treatment of Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00537602 - Recruiting
  Cystic Fibrosis
  
• Coping Compliance and Adjustment in Adolescents With Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00577252 - Recruiting
  Cystic Fibrosis
  
• PTC124 for Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00234663 - Active, not recruiting
  Cystic Fibrosis
  
• Liver Fibrosis in HIV-Infected Patients With Elevated Liver Enzymes on Antiretroviral Therapy
  ClinicalTrials.gov Identifier: NCT00326482 - Recruiting
  Liver Fibrosis
  
• Prevalence and Treatment of Urinary Incontinence in Women With Cystic Fibrosis and Chronic Obstructive Pulmonary Disease
  ClinicalTrials.gov Identifier: NCT00164138 - Active, not recruiting
  Cystic Fibrosis; Chronic Obstructive Pulmonary Disease (COPD)
  
• Sildenafil Trial of Exercise Performance in Idiopathic Pulmonary Fibrosis
  ClinicalTrials.gov Identifier: NCT00517933 - Recruiting
  Pulmonary Fibrosis; Hypertension, Pulmonary
  
• Amiloride Solution and Tobramycin Solution for Inhalation for the Eradication of Burkholderia Dolosa in Patients With Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00547053 - Recruiting
  Cystic Fibrosis
  
• Phase I, Open-Label, Multi-Center, SIngle-Dose, Dose-Escalating, Safety, Tolerability and Pharmacokinetic Study of GC1008 in Patients with IPF
  ClinicalTrials.gov Identifier: NCT00125385 - Active, not recruiting
  Idiopathic Pulmonary Fibrosis; IPF
  
• Improving Vitamin D Status In Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00450073 - Recruiting
  Cystic Fibrosis
  
• PTC124 for Pediatric Patients With Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00458341 - Recruiting
  Cystic Fibrosis
  
• Explanted Lung Tissues With Pulmonary Fibrosis
  ClinicalTrials.gov Identifier: NCT00515567 - Recruiting
  Pulmonary Fibrosis
  
• Absorptive Clearance in the Cystic Fibrosis Airway
  ClinicalTrials.gov Identifier: NCT00541190 - Recruiting
  Cystic Fibrosis
  
• IGF-1 Therapy in Patients With Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00566241 - Recruiting
  Cystic Fibrosis
  
• Studying Patients with Cystic Fibrosis and Other Pulmonary and Pancreatic Disorders
  ClinicalTrials.gov Identifier: NCT00001223 - Recruiting
  Bronchiectasis; Cystic Fibrosis; Pancreatic Insufficiency
  
• Lumbar Spinal Fibrosis and TNF Alpha Inhibition
  ClinicalTrials.gov Identifier: NCT00385086 - Recruiting
  Post Operative Sciatica by Lumbar Spinal Fibrosis
  
• Nasal Inhalation of Pulmozyme in Patients With Cystic Fibrosis and Chronic Rhinosinusitis
  ClinicalTrials.gov Identifier: NCT00534079 - Recruiting
  Cystic Fibrosis; Rhinosinusitis
  
• Efficacy and Safety of ULTRASE MT20 in Improving the Coefficient of Fat Absorption (CFA%) in Children With Cystic Fibrosis (CF) and Pancreatic Insufficiency (PI)
  ClinicalTrials.gov Identifier: NCT00513682 - Recruiting
  Cystic Fibrosis; Pancreatic Insufficiency
  
• Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.
  ClinicalTrials.gov Identifier: NCT00323804 - Recruiting
  Hepatitis C, Chronic; Liver Fibrosis
  
• A Trial of Pulmozyme Withdrawal on Exercise Tolerance in Cystic Fibrosis Subjects With Severe Lung Disease (TOPIC)
  ClinicalTrials.gov Identifier: NCT00434278 - Recruiting
  Cystic Fibrosis; Lung Disease
  
• Treatment of Idiopathic Pulmonary Fibrosis With Long Acting Octreotide
  ClinicalTrials.gov Identifier: NCT00463983 - Recruiting
  Idiopathic Pulmonary Fibrosis